| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| IL-5 R alpha | Human IL-5 R alpha / CD125 Protein, Fc Tag (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $410.00 100ug | ||
| IL-5 R alpha | Human IL-5 R alpha / CD125 Protein, His Tag, low endotoxin (Mass Spec & MALS & BLI verified) | Human | HEK293 |  | MALSSDS-PAGE | $325.00 50ug | ||
| IL-5 R alpha | Avitag ILA-H82F5 | Biotinylated Human IL-5 R alpha / CD125 Protein, Avitag™,Fc Tag (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug | |
| IL-5 R alpha | Mouse IL-5 R alpha / CD125 Protein, His Tag (MALS & SPR verified) |  Mouse | HEK293 |  | MALSSDS-PAGE | $350.00 100ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| IL-5 CAR-T Cell Therapy (Zhejiang University) | Phase 1 Clinical | Zhejiang University | Hematologic Diseases; Neoplasms | 상세 | |
| Trabikibart | CSL-311 | Phase 1 Clinical | Csl Ltd | Asthma | 상세 |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 가장 빠른 브랜드 이름 | 가장 빠른 승인 국가 | 가장 빠른 적응증 | 가장 빠른 승인 회사 | 가장 빠른 승인 날짜 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|---|---|---|---|---|
| Benralizumab | KHK-4563; MEDI-563; BIW-8405; BIW-8405-IL-5R | Approved | Biowa Inc, Medimmune Llc | Fasenra, 凡舒卓 | United States | Asthma | Astrazeneca Ab | 2017-11-14 | Asthma; Asthma, Exercise-Induced; Bronchiectasis; Chronic Urticaria; Dermatitis; Dermatitis, Atopic; Drug Hypersensitivity Syndrome; Eczema; Eosinophilia; Eosinophilic Asthma; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Eosinophilic Granulomatosis With Polyangiitis; Gastroenteritis; Genetic Diseases, Inborn; Granulomatosis with Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases; Leukocyte Disorders; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Sinusitis; Skin Diseases; Skin Diseases, Eczematous; Skin Diseases, Genetic | 상세 |
